Publications 2020

Chandra A, Midtvedt K, Åsberg A, Eide IA (2020)
The Authors' Reply: Placental Pathology in Pregnancies After Kidney Transplantation
Transplantation, 104 (7), e216
DOI 10.1097/TP.0000000000003120, PubMed 32569005

Gustavsen MT, Midtvedt K, Vethe NT, Robertsen I, Bergan S, Åsberg A (2020)
Tacrolimus Area Under the Concentration Versus Time Curve Monitoring, Using Home-Based Volumetric Absorptive Capillary Microsampling
Ther Drug Monit, 42 (3), 407-414
DOI 10.1097/FTD.0000000000000697, PubMed 31479042

Haugen AJ, Hallan S, Langberg NE, Dahle DO, Pihlstrøm H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjøen G (2020)
Increased long-term risk for hypertension in kidney donors - a retrospective cohort study
Transpl Int, 33 (5), 536-543
DOI 10.1111/tri.13576, PubMed 31958170

Klaasen RA, Bergan S, Bremer S, Hole K, Nordahl CB, Andersen AM, Midtvedt K, Skauby MH, Vethe NT (2020)
Pharmacodynamic assessment of mycophenolic acid in resting and activated target cell population during the first year after renal transplantation
Br J Clin Pharmacol, 86 (6), 1100-1112
DOI 10.1111/bcp.14218, PubMed 31925806

Lorentzen EM, Henriksen S, Kaur A, Kro GB, Hammarström C, Hirsch HH, Midtvedt K, Rinaldo CH (2020)
Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor
Virol J, 17 (1), 5
DOI 10.1186/s12985-019-1275-9, PubMed 31924245

Publications 2019

Chandra A, Midtvedt K, Åsberg A, Eide IA (2019)
Immunosuppression and Reproductive Health After Kidney Transplantation
Transplantation, 103 (11), e325-e333
DOI 10.1097/TP.0000000000002903, PubMed 31397802

Eide IA, Rashidi F, Lønning K, Oldereid NB, Reisæter AV, Åsberg A, Midtvedt K (2019)
Contraceptive Choices and Counseling in Norwegian Female Renal Transplant Recipients
Transplant Proc, 51 (2), 470-474
DOI 10.1016/j.transproceed.2019.01.068, PubMed 30879570

Gustavsen MT, Midtvedt K, Lønning K, Jacobsen T, Reisaeter AV, De Geest S, Andersen MH, Hartmann A, Åsberg A (2019)
Evaluation of tools for annual capture of adherence to immunosuppressive medications after renal transplantation - a single-centre open prospective trial
Transpl Int, 32 (6), 614-625
DOI 10.1111/tri.13412, PubMed 30770608

Halden TAS, Kvitne KE, Midtvedt K, Rajakumar L, Robertsen I, Brox J, Bollerslev J, Hartmann A, Åsberg A, Jenssen T (2019)
Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus
Diabetes Care, 42 (6), 1067-1074
DOI 10.2337/dc19-0093, PubMed 30862658

Haugen AJ, Langberg NE, Dahle DO, Pihlstrøm H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjøen G (2019)
Long-term risk for kidney donors with hypertension at donation - a retrospective cohort study
Transpl Int, 32 (9), 960-964
DOI 10.1111/tri.13443, PubMed 30983060

Heldal K, Midtvedt K, Lønning K, Iversen T, Hernæs KH, Tsarpali V, Reisæter AV, Bernklev T (2019)
Kidney transplantation: an attractive and cost-effective alternative for older patients? A cost-utility study
Clin Kidney J, 12 (6), 888-894
DOI 10.1093/ckj/sfz018, PubMed 31807304

Klaasen RA, Egeland EJ, Chan J, Midtvedt K, Svensson M, Bolstad N, Fellström B, Holdaas H, Åsberg A, Bergan S, Vethe NT, Warren DJ (2019)
A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients
Ther Drug Monit, 41 (1), 11-18
DOI 10.1097/FTD.0000000000000580, PubMed 30633722

Midtvedt K, Robertsen I, Asberg A (2019)
Generic drugs - not as similar as we think?
Tidsskr. Nor. Laegeforen., 139 (18), 1722

Midtvedt K, Robertsen I, Åsberg A (2019)
Generic drugs – not as equivalent as we think?
Tidsskr Nor Laegeforen, 139 (18)
DOI 10.4045/tidsskr.19.0740, PubMed 31823584

Vethe NT, Gustavsen MT, Midtvedt K, Lauritsen ME, Andersen AM, Åsberg A, Bergan S (2019)
Tacrolimus Can Be Reliably Measured With Volumetric Absorptive Capillary Microsampling Throughout the Dose Interval in Renal Transplant Recipients
Ther Drug Monit, 41 (5), 607-614
DOI 10.1097/FTD.0000000000000655, PubMed 31584926

Publications 2018

Egeland EJ, Reisaeter AV, Robertsen I, Midtvedt K, Strøm EH, Holdaas H, Hartmann A, Åsberg A (2018)
High tacrolimus clearance - a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single-center cohort study
Transpl Int, 32 (3), 257-269
DOI 10.1111/tri.13356, PubMed 30252957

Egeland EJ, Størset E, Robertsen I, Hermann M, Midtvedt K, Gustavsen MT, Klaasen R, Bergan S, Hartmann A, Åsberg A (2018)
The Authors' Reply
Transplantation, 102 (1), e43-e44
DOI 10.1097/TP.0000000000001961, PubMed 28957846

Foss S, Nordheim E, Sørensen DW, Syversen TB, Midtvedt K, Åsberg A, Dahl T, Bakkan PA, Foss AE, Geiran OR, Fiane AE, Line PD (2018)
First Scandinavian Protocol for Controlled Donation After Circulatory Death Using Normothermic Regional Perfusion
Transplant Direct, 4 (7), e366
DOI 10.1097/TXD.0000000000000802, PubMed 30046656

García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Reisaeter AV, Seron D (2018)
Kidney allograft subclinical rejection modulates systemic inflammation measured by C-reactive protein at 1 year after transplantation
Clin Transplant, 32 (3), e13196
DOI 10.1111/ctr.13196, PubMed 29380890

Heldal K, Midtvedt K, Hartmann A, Reisaeter AV, Heldal TF, Bergan S, Salvador CL, Åsberg A (2018)
Estimated glomerular filtration rate in stable older kidney transplant recipients-are present algorithms valid? A national cross-sectional cohort study
Transpl Int, 31 (6), 629-638
DOI 10.1111/tri.13137, PubMed 29453878

Klaasen RA, Bergan S, Bremer S, Daleq L, Andersen AM, Midtvedt K, Skauby MH, Vethe NT (2018)
Longitudinal Study of Tacrolimus in Lymphocytes During the First Year After Kidney Transplantation
Ther Drug Monit, 40 (5), 558-566
DOI 10.1097/FTD.0000000000000539, PubMed 30086087

Lønning K, Heldal K, Bernklev T, Brunborg C, Andersen MH, von der Lippe N, Reisæter AV, Line PD, Hartmann A, Midtvedt K (2018)
Improved Health-Related Quality of Life in Older Kidney Recipients 1 Year After Transplantation
Transplant Direct, 4 (4), e351
DOI 10.1097/TXD.0000000000000770, PubMed 29707622

Lønning K, Midtvedt K, Bernklev T, Brunborg C, Andersen MH, von der Lippe N, Reisaeter AV, Line PD, Hartmann A, Heldal K (2018)
Changes in health-related quality of life in older candidates waiting for kidney transplantation
Nephrology (Carlton), 23 (10), 948-956
DOI 10.1111/nep.13117, PubMed 28734131

Lønning K, Midtvedt K, Heldal K, Andersen MH (2018)
Older kidney transplantation candidates' expectations of improvement in life and health following kidney transplantation: semistructured interviews with enlisted dialysis patients aged 65 years and older
BMJ Open, 8 (6), e021275
DOI 10.1136/bmjopen-2017-021275, PubMed 29934388

Nordheim E, Horneland R, Aandahl EM, Grzyb K, Aabakken L, Paulsen V, Midtvedt K, Hartmann A, Jenssen T (2018)
Pancreas transplant rejection episodes are not revealed by biopsies of the donor duodenum in a prospective study with paired biopsies
Am J Transplant, 18 (5), 1256-1261
DOI 10.1111/ajt.14658, PubMed 29316221

Nordheim E, Olafsson Storrø M, Natvik AK, Birkeland Kro G, Midtvedt K, Varberg Reisaeter A, Hagness M, Fevang B, Pettersen FO (2018)
Donor-derived strongyloidiasis after organ transplantation in Norway
Transpl Infect Dis, 21 (1), e13008
DOI 10.1111/tid.13008, PubMed 30295406

Publications 2017

Bremer S, Vethe NT, Skauby M, Kasbo M, Johansson ED, Midtvedt K, Bergan S (2017)
NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantation
Br J Clin Pharmacol, 83 (11), 2494-2502
DOI 10.1111/bcp.13367, PubMed 28686294

Dahle DO, Grotmol T, Leivestad T, Hartmann A, Midtvedt K, Reisæter AV, Mjøen G, Pihlstrøm HK, Næss H, Holdaas H (2017)
Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients
Transplantation, 101 (10), 2599-2605
DOI 10.1097/TP.0000000000001659, PubMed 28207636

Egeland EJ, Robertsen I, Hermann M, Midtvedt K, Størset E, Gustavsen MT, Reisæter AV, Klaasen R, Bergan S, Holdaas H, Hartmann A, Åsberg A (2017)
High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation
Transplantation, 101 (8), e273-e279
DOI 10.1097/TP.0000000000001796, PubMed 28452920

García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Seron D, Reisæter AV (2017)
Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies
Transplantation, 101 (6), 1410-1415
DOI 10.1097/TP.0000000000001216, PubMed 27163535

Heldal K, Hartmann A, Lønning K, Leivestad T, Reisæter AV, Line PD, Holdaas H, Midtvedt K (2017)
Should patients older than 65 years be offered a second kidney transplant?
BMC Nephrol, 18 (1), 13
DOI 10.1186/s12882-016-0426-0, PubMed 28077080

Hole K, Størset E, Olastuen A, Haslemo T, Kro GB, Midtvedt K, Åsberg A, Molden E (2017)
Recovery of CYP3A Phenotype after Kidney Transplantation
Drug Metab Dispos, 45 (12), 1260-1265
DOI 10.1124/dmd.117.078030, PubMed 28928137

Lindahl JP, Massey RJ, Hartmann A, Aakhus S, Endresen K, Günther A, Midtvedt K, Holdaas H, Leivestad T, Horneland R, Øyen O, Jenssen T (2017)
Cardiac Assessment of Patients With Type 1 Diabetes Median 10 Years After Successful Simultaneous Pancreas and Kidney Transplantation Compared With Living Donor Kidney Transplantation
Transplantation, 101 (6), 1261-1267
DOI 10.1097/TP.0000000000001274, PubMed 27467687

Midtvedt K, Bergan S, Reisæter AV, Vikse BE, Åsberg A (2017)
Exposure to Mycophenolate and Fatherhood
Transplantation, 101 (7), e214-e217
DOI 10.1097/TP.0000000000001747, PubMed 28346297

Midtvedt K, Holdaas H, Bergan S, Åsberg A (2017)
Costimulation Blockade: America First, Canada Second … What About Norway?
Am J Transplant, 17 (8), 2230
DOI 10.1111/ajt.14351, PubMed 28508535

Midtvedt K, Åsberg A (2017)
Mycophenolate Acid and Balancing the Risk for Male Allograft Recipients
Transplantation, 101 (1), e39
DOI 10.1097/TP.0000000000001509, PubMed 27748704

Pihlstrøm HK, Gatti F, Hammarström C, Eide IA, Kasprzycka M, Wang J, Haraldsen G, Svensson MHS, Midtvedt K, Mjøen G, Dahle DO, Hartmann A, Holdaas H (2017)
Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study
Transpl Int, 30 (8), 827-840
DOI 10.1111/tri.12973, PubMed 28436117

Pippias M, Jager KJ, Caskey F, Casula A, Erlandsson H, Finne P, Heaf J, Heinze G, Hoitsma A, Kramar R, Lempinen M, Magaz A, Midtvedt K, Mumford LL, Pascual J, Prütz KG, Sørensen SS, Traynor JP, Massy ZA, Ravanan R, Stel VS (2017)
Kidney transplant outcomes from older deceased donors: a paired kidney analysis by the European Renal Association-European Dialysis and Transplant Association Registry
Transpl Int, 31 (7), 708-719
DOI 10.1111/tri.13103, PubMed 29210108

Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2017)
Response to: 'Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'
Br J Clin Pharmacol, 83 (6), 1357-1358
DOI 10.1111/bcp.13276, PubMed 28374426

Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2017)
The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation
Br J Clin Pharmacol, 83 (7), 1457-1465
DOI 10.1111/bcp.13248, PubMed 28146606

Torres IB, Reisaeter AV, Moreso F, Âsberg A, Vidal M, Garcia-Carro C, Midtvedt K, Reinholt FP, Scott H, Castellà E, Salcedo M, Dörje C, Sellarés J, Azancot MA, Perello M, Holdaas H, Serón D (2017)
Tacrolimus and mycophenolate regimen and subclinical tubulo-interstitial inflammation in low immunological risk renal transplants
Transpl Int, 30 (11), 1119-1131
DOI 10.1111/tri.13002, PubMed 28667664

Åsberg A, Robertsen I, Midtvedt K (2017)
How to Report and Interpret Bioequivalence Data in Solid Organ Transplant Recipients
Transplantation, 101 (11), e347
DOI 10.1097/TP.0000000000001894, PubMed 28787310

Publications 2016

Dörje C, Reisaeter AV, Dahle DO, Mjøen G, Midtvedt K, Holdaas H, Flaa-Johnsen L, Syversveen T, Hartmann A, Jenssen T, Scott H, Reinholt FP (2016)
Total inflammation in early protocol kidney graft biopsies does not predict progression of fibrosis at one year post-transplant
Clin Transplant, 30 (7), 802-9
DOI 10.1111/ctr.12753, PubMed 27101801

Halden TA, Egeland EJ, Åsberg A, Hartmann A, Midtvedt K, Khiabani HZ, Holst JJ, Knop FK, Hornum M, Feldt-Rasmussen B, Jenssen T (2016)
GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation Diabetes
Diabetes Care, 39 (4), 617-24
DOI 10.2337/dc15-2383, PubMed 26908914

Lønning K, Midtvedt K, Leivestad T, Reisæter AV, Line PD, Hartmann A, Heldal K (2016)
Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?
Transplantation, 100 (12), 2705-2709
DOI 10.1097/TP.0000000000001363, PubMed 27861296

Mjøen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2016)
Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
Nephrol Dial Transplant, 31 (1), 170
DOI 10.1093/ndt/gfv397, PubMed 26740671

Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2016)
Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance
Br J Clin Pharmacol, 83 (6), 1350-1352
DOI 10.1111/bcp.13188, PubMed 28008657

Størset E, von Düring ME, Godang K, Bergan S, Midtvedt K, Åsberg A (2016)
Prediction of Fat-Free Mass in Kidney Transplant Recipients
Ther Drug Monit, 38 (4), 439-46
DOI 10.1097/FTD.0000000000000305, PubMed 27019101

Størset E, Åsberg A, Hartmann A, Reisaeter AV, Holdaas H, Skauby M, Bergan S, Midtvedt K (2016)
Low-target tacrolimus in de novo standard risk renal transplant recipients: A single-centre experience
Nephrology (Carlton), 21 (10), 821-7
DOI 10.1111/nep.12738, PubMed 26854648

Publications 2015

Dörje C, Mjøen G, Strøm EH, Holdaas H, Jenssen T, Øyen O, Akkök ÇA, Cvancarova M, Midtvedt K, Reisaeter AV (2015)
One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts
Clin Transplant, 29 (3), 268-76
DOI 10.1111/ctr.12515, PubMed 25644963

Lindahl JP, Hartmann A, Aakhus S, Endresen K, Midtvedt K, Holdaas H, Leivestad T, Horneland R, Øyen O, Jenssen T (2015)
Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantation
Diabetologia, 59 (4), 844-52
DOI 10.1007/s00125-015-3853-8, PubMed 26713324

Murbraech K, Massey R, Undset LH, Midtvedt K, Holdaas H, Aakhus S (2015)
Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients--a three-yr serial echocardiographic substudy of the randomized controlled CENTRAL trial
Clin Transplant, 29 (8), 678-84
DOI 10.1111/ctr.12565, PubMed 25982053

Robertsen I, Vethe NT, Midtvedt K, Falck P, Christensen H, Åsberg A (2015)
Closer to the Site of Action: Everolimus Concentrations in Peripheral Blood Mononuclear Cells Correlate Well With Whole Blood Concentrations
Ther Drug Monit, 37 (5), 675-80
DOI 10.1097/FTD.0000000000000185, PubMed 25565673

Robertsen I, Åsberg A, Ingerø AO, Vethe NT, Bremer S, Bergan S, Midtvedt K (2015)
Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed
Transplantation, 99 (3), 528-32
DOI 10.1097/TP.0000000000000384, PubMed 25148382

Størset E, Åsberg A, Skauby M, Neely M, Bergan S, Bremer S, Midtvedt K (2015)
Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study
Transplantation, 99 (10), 2158-66
DOI 10.1097/TP.0000000000000708, PubMed 25886918

Publications 2014

Dörje C, Midtvedt K, Reisæter AV (2014)
Analysis of predictive and preventive factors for de novo donor-specific antibodies in kidney transplant recipientsy--is nonadherence of importance?
Transplantation, 98 (4), e31
DOI 10.1097/TP.0000000000000330, PubMed 25243517

Hirsch HH, Babel N, Comoli P, Friman V, Ginevri F, Jardine A, Lautenschlager I, Legendre C, Midtvedt K, Muñoz P, Randhawa P, Rinaldo CH, Wieszek A, ESCMID Study Group of Infection in Compromised Hosts (2014)
European perspective on human polyomavirus infection, replication and disease in solid organ transplantation
Clin Microbiol Infect, 20 Suppl 7, 74-88
DOI 10.1111/1469-0691.12538, PubMed 24476010

Lindahl JP, Reinholt FP, Eide IA, Hartmann A, Midtvedt K, Holdaas H, Dorg LT, Reine TM, Kolset SO, Horneland R, Øyen O, Brabrand K, Jenssen T (2014)
In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone
Diabetologia, 57 (11), 2357-65
DOI 10.1007/s00125-014-3353-2, PubMed 25145544

Lunde I, Bremer S, Midtvedt K, Mohebi B, Dahl M, Bergan S, Åsberg A, Christensen H (2014)
The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
Eur J Clin Pharmacol, 70 (6), 685-93
DOI 10.1007/s00228-014-1656-3, PubMed 24658827

Midtvedt K, Heldal K (2014)
Chronic kidney disease and the aging population
Transplantation, 97 (11), e64
DOI 10.1097/TP.0000000000000172, PubMed 24887750

Pihlstrøm H, Mjøen G, Dahle DO, Pilz S, Midtvedt K, März W, Abedini S, Holme I, Fellström B, Jardine A, Holdaas H (2014)
Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipients
Transplantation, 98 (11), 1219-25
DOI 10.1097/TP.0000000000000205, PubMed 24999963

Robertsen I, Asberg A, Granseth T, Vethe NT, Akhlaghi F, Ghareeb M, Molden E, Reier-Nilsen M, Holdaas H, Midtvedt K (2014)
More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients
Transplantation, 97 (12), 1266-71
DOI 10.1097/01.TP.0000443225.66960.7e, PubMed 24521776

Størset E, Holford N, Hennig S, Bergmann TK, Bergan S, Bremer S, Åsberg A, Midtvedt K, Staatz CE (2014)
Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling
Br J Clin Pharmacol, 78 (3), 509-23
DOI 10.1111/bcp.12361, PubMed 25279405

Publications 2013

Dahle DO, Midtvedt K, Hartmann A, Jenssen T, Holdaas H, Mjøen G, Leivestad T, Asberg A (2013)
Endothelial dysfunction is associated with graft loss in renal transplant recipients
Transplantation, 95 (5), 733-9
DOI 10.1097/TP.0b013e31827d6312, PubMed 23364481

Dörje C, Midtvedt K, Holdaas H, Naper C, Strøm EH, Øyen O, Leivestad T, Aronsen T, Jenssen T, Flaa-Johnsen L, Lindahl JP, Hartmann A, Reisæter AV (2013)
Early versus late acute antibody-mediated rejection in renal transplant recipients
Transplantation, 96 (1), 79-84
DOI 10.1097/TP.0b013e31829434d4, PubMed 23632391

Heldal K, Midtvedt K (2013)
Managing transplant rejection in the elderly: the benefits of less aggressive immunosuppressive regimens
Drugs Aging, 30 (7), 459-66
DOI 10.1007/s40266-013-0082-z, PubMed 23609876

Heldal K, Thorarinsdottir S, Hartmann A, Leivestad T, Reisæter AV, Foss AE, Midtvedt K (2013)
Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study
Transplant Res, 2 (1), 11
DOI 10.1186/2047-1440-2-11, PubMed 23799993

Lindahl JP, Hartmann A, Horneland R, Holdaas H, Reisæter AV, Midtvedt K, Leivestad T, Oyen O, Jenssen T (2013)
Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease
Diabetologia, 56 (6), 1364-71
DOI 10.1007/s00125-013-2888-y, PubMed 23549518

Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O, Reisæter A, Pfeffer P, Jenssen T, Leivestad T, Line PD, Øvrehus M, Dale DO, Pihlstrøm H, Holme I, Dekker FW, Holdaas H (2013)
Long-term risks for kidney donors
Kidney Int, 86 (1), 162-7
DOI 10.1038/ki.2013.460, PubMed 24284516

Størset E, Holford N, Midtvedt K, Bremer S, Bergan S, Åsberg A (2013)
Importance of hematocrit for a tacrolimus target concentration strategy
Eur J Clin Pharmacol, 70 (1), 65-77
DOI 10.1007/s00228-013-1584-7, PubMed 24071959

Åsberg A, Midtvedt K, van Guilder M, Størset E, Bremer S, Bergan S, Jelliffe R, Hartmann A, Neely MN (2013)
Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation
Transpl Int, 26 (12), 1198-207
DOI 10.1111/tri.12194, PubMed 24118301

Publications 2012

Brabrand K, Midtvedt K, Günther A, Marthinsen PB, Berstad AE (2012)
Color Doppler ultrasound-guided transducer compression of post biopsy bleeding of kidney transplants
J Clin Ultrasound, 41 (1), 26-31
DOI 10.1002/jcu.21983, PubMed 22927091

Hausken J, Klingenberg O, Mørkrid L, Rollag H, Foss A, Midtvedt K (2012)
Elevated troponin I and NT-proBNP at the time of transplantation may predict a major adverse cardiac event in the early postoperative period after renal transplantation
Transplantation, 94 (2), e15-6
DOI 10.1097/TP.0b013e31825b7633, PubMed 22820562

Heldal K, Midtvedt K (2012)
Doctor, should I remain on dialysis or accept the ECD kidney offered to me?
Am J Kidney Dis, 59 (6), 748-50
DOI 10.1053/j.ajkd.2012.03.002, PubMed 22613394

Holdaas H, Midtvedt K, Åsberg A (2012)
A drug safety evaluation of everolimus in kidney transplantation
Expert Opin Drug Saf, 11 (6), 1013-22
DOI 10.1517/14740338.2012.722993, PubMed 22954349

Krämer BK, Klinger M, Vítko Š, Glyda M, Midtvedt K, Stefoni S, Citterio F, Pietruck F, Squifflet JP, Segoloni G, Krüger B, Sperschneider H, Banas B, Bäckman L, Weber M, Carmellini M, Perner F, Claesson K, Marcinkowski W, Ostrowski M, Senatorski G, Nordström J, Salmela K (2012)
Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial
Transplantation, 94 (5), 492-8
DOI 10.1097/TP.0b013e31825c1d6c, PubMed 22858806

Loftheim H, Midtvedt K, Hartmann A, Reisæter AV, Falck P, Holdaas H, Jenssen T, Reubsaet L, Asberg A (2012)
Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients
Transplant Res, 1 (1), 9
DOI 10.1186/2047-1440-1-9, PubMed 23369437

Smerud KT, Dolgos S, Olsen IC, Åsberg A, Sagedal S, Reisæter AV, Midtvedt K, Pfeffer P, Ueland T, Godang K, Bollerslev J, Hartmann A (2012)
A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation
Am J Transplant, 12 (12), 3316-25
DOI 10.1111/j.1600-6143.2012.04233.x, PubMed 22946930

Syversveen T, Midtvedt K, Berstad AE, Brabrand K, Strøm EH, Abildgaard A (2012)
Tissue elasticity estimated by acoustic radiation force impulse quantification depends on the applied transducer force: an experimental study in kidney transplant patients
Eur Radiol, 22 (10), 2130-7
DOI 10.1007/s00330-012-2476-4, PubMed 22610533

Publications 2011

Brabrand K, Holdaas H, Gunther A, Midtvedt K (2011)
Spontaneous regression of initially elevated peak systolic velocity in renal transplant artery
Transpl Int, 24 (6), 555-9
DOI 10.1111/j.1432-2277.2011.01233.x, PubMed 21332581

Heldal K, Hartmann A, Leivestad T, Foss A, Midtvedt K (2011)
Risk variables associated with the outcome of kidney recipients >70 years of age in the new millennium
Nephrol Dial Transplant, 26 (8), 2706-11
DOI 10.1093/ndt/gfq786, PubMed 21285131

Heldal K, Hartmann A, Leivestad T, Lien B, Foss AE, Midtvedt K (2011)
Renal transplantation is also an option for patients over 70
Tidsskr Nor Laegeforen, 131 (20), 2004-7
DOI 10.4045/tidsskr.10.1391, PubMed 22016126

Holdaas H, Rostaing L, Serón D, Cole E, Chapman J, Fellstrøm B, Strom EH, Jardine A, Midtvedt K, Machein U, Ulbricht B, Karpov A, O'Connell PJ, ASCERTAIN Investigators (2011)
Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study
Transplantation, 92 (4), 410-8
DOI 10.1097/TP.0b013e318224c12d, PubMed 21697773

Midtvedt K, Holdaas H (2011)
Belatacept: BENEFIT to the kidney?
Am J Transplant, 11 (3), 633; author reply 634
DOI 10.1111/j.1600-6143.2010.03411.x, PubMed 21342454

Midtvedt K, Jenssen T, Hartmann A, Vethe NT, Bergan S, Havnes K, Åsberg A (2011)
No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus
Nephrol Dial Transplant, 26 (11), 3767-72
DOI 10.1093/ndt/gfr153, PubMed 21471328

Midtvedt K, Namtvedt T, Scott H, Abedini S, Rocke JC, Dørje C, Foss S, Christen U, Hagness M, Hartmann A (2011)
Single transplanted kidneys from a 90-year-old deceased donor perform acceptably at 1 year
Transplant Proc, 43 (5), 2107-9
DOI 10.1016/j.transproceed.2011.01.192, PubMed 21693337

Mjøen G, Oyen O, Midtvedt K, Dahle DO, Norby G, Holdaas H (2011)
Age, gender, and body mass index are associated with renal function after kidney donation
Clin Transplant, 25 (6), E579-83
DOI 10.1111/j.1399-0012.2011.01503.x, PubMed 21906171

Mjøen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2011)
Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
Nephrol Dial Transplant, 27 (1), 443-7
DOI 10.1093/ndt/gfr303, PubMed 21636826

Mjøen G, Stavem K, Westlie L, Midtvedt K, Fauchald P, Norby G, Holdaas H (2011)
Quality of life in kidney donors
Am J Transplant, 11 (6), 1315-9
DOI 10.1111/j.1600-6143.2011.03517.x, PubMed 21486387

Norby GE, Leivestad T, Mjøen G, Hartmann A, Midtvedt K, Gran JT, Holdaas H (2011)
Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation
Arthritis Rheum, 63 (3), 733-7
DOI 10.1002/art.30184, PubMed 21360503

Reisaeter AV, Foss A, Hartmann A, Leivestad T, Midtvedt K (2011)
The kidney transplantation program in Norway since 2000
Clin Transpl, 111-8
PubMed 22755407

Syversveen T, Brabrand K, Midtvedt K, Strøm EH, Hartmann A, Berstad AE (2011)
Non-invasive assessment of renal allograft fibrosis by dynamic sonographic tissue perfusion measurement
Acta Radiol, 52 (8), 920-6
DOI 10.1258/ar.2011.110215, PubMed 21873503

Syversveen T, Midtvedt K, Brabrand K, Øyen O, Foss A, Scholz T (2011)
Prophylactic peritoneal fenestration to prevent morbidity after kidney transplantation: a randomized study
Transplantation, 92 (2), 196-202
DOI 10.1097/TP.0b013e318220f57b, PubMed 21597401

Tangeraas T, Midtvedt K, Cvancarova M, Hirth A, Fredriksen PM, Tonstad S, Isaksen GA, Bjerre A (2011)
Cardiorespiratory fitness in young adults with a history of renal transplantation in childhood
Pediatr Nephrol, 26 (11), 2041-9
DOI 10.1007/s00467-011-1898-6, PubMed 21541798

Vethe NT, Midtvedt K, Asberg A, Amundsen R, Bergan S (2011)
[Drug interactions and immunosuppression in organ transplant recipients]
Tidsskr Nor Laegeforen, 131 (20), 2000-3
DOI 10.4045/tidsskr.11.0138, PubMed 22016125

Publications 2010

Asberg A, Falck P, Undset LH, Dørje C, Holdaas H, Hartmann A, Midtvedt K (2010)
Computer-assisted cyclosporine dosing performs better than traditional dosing in renal transplant recipients: results of a pilot study
Ther Drug Monit, 32 (2), 152-8
DOI 10.1097/FTD.0b013e3181d3f822, PubMed 20216113

Mjoen G, Midtvedt K, Holme I, Øyen O, Fauchald P, Bergrem H, Holdaas H (2010)
One- and five-year follow-ups on blood pressure and renal function in kidney donors
Transpl Int, 24 (1), 73-7
DOI 10.1111/j.1432-2277.2010.01148.x, PubMed 20723180

Myhre HA, Øyen O, Kårbø Ø, Midtvedt K (2010)
Successful treatment of spontaneous kidney graft decapsulation 18 years after renal transplantation: a case report
NDT Plus, 3 (1), 100-2
DOI 10.1093/ndtplus/sfp148, PubMed 25949418

Norby GE, Strøm EH, Midtvedt K, Hartmann A, Gilboe IM, Leivestad T, Stenstrøm J, Holdaas H (2010)
Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study
Ann Rheum Dis, 69 (8), 1484-7
DOI 10.1136/ard.2009.122796, PubMed 20498208

Strøm EH, Reinholt FP, Midtvedt K (2010)
JC virus-associated nephropathy: lack of convincing documentation of the diagnosis
Transpl Infect Dis, 13 (1), 93-4
DOI 10.1111/j.1399-3062.2010.00594.x, PubMed 21299773

Syversveen T, Brabrand K, Midtvedt K, Strøm EH, Hartmann A, Jakobsen JA, Berstad AE (2010)
Assessment of renal allograft fibrosis by acoustic radiation force impulse quantification--a pilot study
Transpl Int, 24 (1), 100-5
DOI 10.1111/j.1432-2277.2010.01165.x, PubMed 20819192

Tangeraas T, Midtvedt K, Fredriksen PM, Cvancarova M, Mørkrid L, Bjerre A (2010)
Cardiorespiratory fitness is a marker of cardiovascular health in renal transplanted children
Pediatr Nephrol, 25 (11), 2343-50
DOI 10.1007/s00467-010-1596-9, PubMed 20676694

Publications 2009

Amundsen R, Asberg A, Robertsen I, Vethe NT, Bergan S, Hartmann A, Midtvedt K (2009)
Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipients
Transplantation, 87 (8), 1221-4
DOI 10.1097/TP.0b013e31819f1001, PubMed 19384170

Asberg A, Midtvedt K, Voytovich MH, Line PD, Narverud J, Reisaeter AV, Mørkrid L, Jenssen T, Hartmann A (2009)
Calcineurin inhibitor effects on glucose metabolism and endothelial function following renal transplantation
Clin Transplant, 23 (4), 511-8
DOI 10.1111/j.1399-0012.2009.00962.x, PubMed 19210527

Bremer S, Vethe NT, Rootwelt H, Jørgensen PF, Stenstrøm J, Holdaas H, Midtvedt K, Bergan S (2009)
Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study
J Transl Med, 7, 64
DOI 10.1186/1479-5876-7-64, PubMed 19635156

Falck P, Midtvedt K, Vân Lê TT, Storehagen L, Holdaas H, Hartmann A, Asberg A (2009)
A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients
Clin Pharmacokinet, 48 (9), 615-23
DOI 10.2165/11313380-000000000-00000, PubMed 19725595

Foss A, Heldal K, Scott H, Foss S, Leivestad T, Jørgensen PF, Scholz T, Midtvedt K (2009)
Kidneys from deceased donors more than 75 years perform acceptably after transplantation
Transplantation, 87 (10), 1437-41
DOI 10.1097/TP.0b013e3181a4ebd2, PubMed 19461478

Heldal K, Hartmann A, Grootendorst DC, de Jager DJ, Leivestad T, Foss A, Midtvedt K (2009)
Benefit of kidney transplantation beyond 70 years of age
Nephrol Dial Transplant, 25 (5), 1680-7
DOI 10.1093/ndt/gfp681, PubMed 20038521

Heldal K, Hartmann A, Leivestad T, Svendsen MV, Foss A, Lien B, Midtvedt K (2009)
Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity
Transplantation, 87 (7), 1045-51
DOI 10.1097/TP.0b013e31819cdddd, PubMed 19352126

Midtvedt K, Bitter J, Dørje C, Bjørneklett R, Holdaas H (2009)
Belatacept as immunosuppression in patient with recurrence of hemolytic uremic syndrome after renal transplantation
Transplantation, 87 (12), 1901-3
DOI 10.1097/TP.0b013e3181a991ca, PubMed 19543075

Midtvedt K, Midtvedt T (2009)
[Childhood diarrhea research in developing countries]
Tidsskr Nor Laegeforen, 129 (15), 1484-5
DOI 10.4045/tidsskr.09.0715, PubMed 19690601

Mjøen G, Øyen O, Holdaas H, Midtvedt K, Line PD (2009)
Morbidity and mortality in 1022 consecutive living donor nephrectomies: benefits of a living donor registry
Transplantation, 88 (11), 1273-9
DOI 10.1097/TP.0b013e3181bb44fd, PubMed 19996926

Valderhaug TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, Hjelmesaeth J (2009)
Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation
Transplantation, 88 (3), 429-34
DOI 10.1097/TP.0b013e3181af1f53, PubMed 19667949

Witczak BJ, Leivestad T, Line PD, Holdaas H, Reisaeter AV, Jenssen TG, Midtvedt K, Bitter J, Hartmann A (2009)
Experience from an active preemptive kidney transplantation program--809 cases revisited
Transplantation, 88 (5), 672-7
DOI 10.1097/TP.0b013e3181b27b7e, PubMed 19741464

Aasebø W, Midtvedt K, Valderhaug TG, Leivestad T, Hartmann A, Reisaeter AV, Jenssen T, Holdaas H (2009)
Impaired glucose homeostasis in renal transplant recipients receiving basiliximab
Nephrol Dial Transplant, 25 (4), 1289-93
DOI 10.1093/ndt/gfp617, PubMed 19934089

Publications 2008

Bremer S, Mandla R, Vethe NT, Rasmussen I, Rootwelt H, Line PD, Midtvedt K, Bergan S (2008)
Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression
Transplantation, 85 (1), 55-61
DOI 10.1097/01.tp.0000296854.68123.03, PubMed 18192912

Falck P, Asberg A, Byberg KT, Bremer S, Bergan S, Reubsaet JL, Midtvedt K (2008)
Reduced elimination of cyclosporine A in elderly (>65 years) kidney transplant recipients
Transplantation, 86 (10), 1379-83
DOI 10.1097/TP.0b013e31818aa4b6, PubMed 19034006

Falck P, Asberg A, Guldseth H, Bremer S, Akhlaghi F, Reubsaet JL, Pfeffer P, Hartmann A, Midtvedt K (2008)
Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients
Transplantation, 85 (2), 179-84
DOI 10.1097/TP.0b013e31815feede, PubMed 18212621

Foss A, Gunther A, Line PD, Brabrand K, Holdaas H, Hartmann A, Midtvedt K (2008)
Long-term clinical outcome of paediatric kidneys transplanted to adults
Nephrol Dial Transplant, 23 (2), 726-9
DOI 10.1093/ndt/gfm826, PubMed 18198285

Gunther A, Foss A, Holdaas H, Brabrand K, Hartmann A, Line PD, Midtvedt K (2008)
Increased peak systolic velocity in the renal artery of paediatric kidneys transplanted to adult recipients
Nephrol Dial Transplant, 23 (12), 4041-3
DOI 10.1093/ndt/gfn358, PubMed 18586763

Holdaas H, Bentdal O, Pfeffer P, Mjørnstedt L, Solbu D, Midtvedt K (2008)
Early, abrupt conversion of de novo renal transplant patients from cyclosporine to everolimus: results of a pilot study
Clin Transplant, 22 (3), 366-71
DOI 10.1111/j.1399-0012.2008.00795.x, PubMed 18279419

Publications 2007

Falck P, Guldseth H, Asberg A, Midtvedt K, Reubsaet JL (2007)
Determination of ciclosporin A and its six main metabolites in isolated T-lymphocytes and whole blood using liquid chromatography-tandem mass spectrometry
J Chromatogr B Analyt Technol Biomed Life Sci, 852 (1-2), 345-52
DOI 10.1016/j.jchromb.2007.01.039, PubMed 17301005

Falck P, Vethe NT, Asberg A, Midtvedt K, Bergan S, Reubsaet JL, Holdaas H (2007)
Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients
Nephrol Dial Transplant, 23 (3), 1048-53
DOI 10.1093/ndt/gfm632, PubMed 17956893

Foss A, Line PD, Brabrand K, Midtvedt K, Hartmann A (2007)
A prospective study on size and function of paediatric kidneys (<10 years) transplanted to adults
Nephrol Dial Transplant, 22 (6), 1738-42
DOI 10.1093/ndt/gfm080, PubMed 17384415

Heldal K, Leivestad T, Hartmann A, Svendsen MV, Lien BH, Midtvedt K (2007)
Kidney transplantation in the elderly--the Norwegian experience
Nephrol Dial Transplant, 23 (3), 1026-31
DOI 10.1093/ndt/gfm719, PubMed 18079146

Hjelmesaeth J, Hagen LT, Asberg A, Midtvedt K, Størset O, Halvorsen CE, Mørkrid L, Hartmann A, Jenssen T (2007)
The impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man
Nephrol Dial Transplant, 22 (6), 1743-9
DOI 10.1093/ndt/gfl820, PubMed 17299003

Midtvedt K, Bjorang O, Letting AS (2007)
Successful pregnancy in renal transplant recipient with previous known polyomavirus nephropathy
Clin Transplant, 21 (4), 571-3
DOI 10.1111/j.1399-0012.2007.00673.x, PubMed 17645722

Publications 2006

Asberg A, Midtvedt K, Line PD, Narverud J, Holdaas H, Jenssen T, Reisaeter AV, Johnsen LF, Fauchald P, Hartmann A (2006)
Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients
Transplantation, 82 (1), 62-8
DOI 10.1097/01.tp.0000225803.04995.2b, PubMed 16861943

Boberg KM, Foss A, Midtvedt K, Schrumpf E (2006)
ABO-incompatible deceased donor liver transplantation with the use of antigen-specific immunoadsorption and anti-CD20 monoclonal antibody
Clin Transplant, 20 (2), 265-8
DOI 10.1111/j.1399-0012.2005.00470.x, PubMed 16640538

Mandla R, Midtvedt K, Line PD, Hartmann A, Bergan S (2006)
Mycophenolic acid clinical pharmacokinetics influenced by a cyclosporine C2 based immunosuppressive regimen in renal allograft recipients
Transpl Int, 19 (1), 44-53
DOI 10.1111/j.1432-2277.2005.00228.x, PubMed 16359376

Midtvedt K, Brabrand K (2006)
[Hemodynamic renal changes in right-sided heart failure]
Tidsskr Nor Laegeforen, 126 (10), 1356; author reply 1356
PubMed 16691279

Olsen GH, Andresen PA, Hilmarsen HT, Bjørang O, Scott H, Midtvedt K, Rinaldo CH (2006)
Genetic variability in BK Virus regulatory regions in urine and kidney biopsies from renal-transplant patients
J Med Virol, 78 (3), 384-93
DOI 10.1002/jmv.20551, PubMed 16419108

Oyen O, Strøm EH, Midtvedt K, Bentdal O, Hartmann A, Bergan S, Pfeffer P, Brekke IB (2006)
Calcineurin inhibitor-free immunosuppression in renal allograft recipients with thrombotic microangiopathy/hemolytic uremic syndrome
Am J Transplant, 6 (2), 412-8
DOI 10.1111/j.1600-6143.2005.01184.x, PubMed 16426329

Vethe NT, Mandla R, Line PD, Midtvedt K, Hartmann A, Bergan S (2006)
Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment
Scand J Clin Lab Invest, 66 (1), 31-44
DOI 10.1080/00365510500420259, PubMed 16464785

Publications 2005

Büchler M, Chadban S, Cole E, Midtvedt K, Thervet E, Prestele H, Keown P (2005)
Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases
Nephrol Dial Transplant, 21 (1), 197-202
DOI 10.1093/ndt/gfi113, PubMed 16204301

Kvale EØ, Dalgaard J, Lund-Johansen F, Rollag H, Farkas L, Midtvedt K, Jahnsen FL, Brinchmann JE, Olweus J (2005)
CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection
Blood, 107 (5), 2022-9
DOI 10.1182/blood-2005-05-2016, PubMed 16269620

Midtvedt K (2005)
[Infections in immunosuppressed children]
Tidsskr Nor Laegeforen, 125 (13), 1884; author reply 1884
PubMed 16012580

Nashan B, Bock A, Bosmans JL, Budde K, Fijter H, Jaques B, Johnston A, Lück R, Midtvedt K, Pallardó LM, Ready A, Salamé E, Salizzoni M, Suarez F, Thervet E (2005)
Use of Neoral C monitoring: a European consensus
Transpl Int, 18 (7), 768-78
DOI 10.1111/j.1432-2277.2005.00151.x, PubMed 15948854

Aasebø W, Midtvedt K, Hartmann A, Stavem K (2005)
Predictors of health-related quality of life in hypertensive recipients following renal transplantation
Clin Transplant, 19 (6), 756-62
DOI 10.1111/j.1399-0012.2005.00416.x, PubMed 16313321

Publications 2004

Hartmann A, Midtvedt K, Witczak B (2004)
[Kidney injuries and kidney failure caused by drugs]
Tidsskr Nor Laegeforen, 124 (21), 2765-6
PubMed 15534671

Midtvedt K (2004)
Therapeutic drug monitoring of cyclosporine
Transplant Proc, 36 (2 Suppl), 430S-433S
DOI 10.1016/j.transproceed.2004.01.025, PubMed 15041380

Midtvedt K, Hjelmesaeth J, Hartmann A, Lund K, Paulsen D, Egeland T, Jenssen T (2004)
Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal
J Am Soc Nephrol, 15 (12), 3233-9
DOI 10.1097/01.ASN.0000145435.80005.1E, PubMed 15579527

Publications 2003

Mandla R, Line PD, Midtvedt K, Bergan S (2003)
Automated determination of free mycophenolic acid and its glucuronide in plasma from renal allograft recipients
Ther Drug Monit, 25 (3), 407-14
DOI 10.1097/00007691-200306000-00025, PubMed 12766573

Midtvedt K, Fauchald P, Bergan S, Høieggen A, Hallan S, Svarstad E, Bergrem H, Eriksen BO, Pfeffer PF, Dalen I, Leivestad T (2003)
C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
Transplantation, 76 (8), 1236-8
DOI 10.1097/01.TP.0000085046.39523.D5, PubMed 14578761

Midtvedt K, Fauchald P, Lien B, Hartmann A, Albrechtsen D, Bjerkely BL, Leivestad T, Brekke IB (2003)
Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection
Clin Transplant, 17 (1), 69-74
DOI 10.1034/j.1399-0012.2003.02105.x, PubMed 12588325

Sagedal S, Nordal KP, Hartmann A, Midtvedt K, Foss A, Asberg A, Degré M, Fauchald P, Rollag H (2003)
Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study
Nephrol Dial Transplant, 18 (9), 1899-908
DOI 10.1093/ndt/gfg302, PubMed 12937241

Publications 2002

Bjorang O, Tveitan H, Midtvedt K, Broch LU, Scott H, Andresen PA (2002)
Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient
Nephrol Dial Transplant, 17 (11), 2023-5
DOI 10.1093/ndt/17.11.2023, PubMed 12401867

Cole E, Midtvedt K, Johnston A, Pattison J, O'Grady C (2002)
Recommendations for the implementation of Neoral C(2) monitoring in clinical practice
Transplantation, 73 (9 Suppl), S19-22
DOI 10.1097/00007890-200205151-00004, PubMed 12023609

Hartmann A, Jenssen T, Midtvedt K, Reisaeter AV, Fauchald P, Henriksen T, Monn E, Christophersen B (2002)
[Protein-creatinine ratio--a simple method for proteinuria assessment in clinical practice]
Tidsskr Nor Laegeforen, 122 (22), 2180-3
PubMed 12426892

Heldal K, Midtvedt K (2002)
[Licorice--not just candy]
Tidsskr Nor Laegeforen, 122 (8), 774-6
PubMed 12092066

Hjelmesaeth J, Hagen M, Hartmann A, Midtvedt K, Egeland T, Jenssen T (2002)
The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation
Clin Transplant, 16 (6), 389-96
DOI 10.1034/j.1399-0012.2002.02059.x, PubMed 12437616

Hjelmesaeth J, Midtvedt K, Jenssen T, Hartmann A (2002)
Insulin resistance after renal transplantation
Diabetes Care, 25 (7), 1260-1261

Midtvedt K, Hartmann A (2002)
Response to "Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared with lisinopril"
Transplantation, 74 (1), UNSP 0041-1337/02/7401-139/0-140

Midtvedt K, Hartmann A (2002)
Hypertension after kidney transplantation: are treatment guidelines emerging?
Nephrol Dial Transplant, 17 (7), 1166-9
DOI 10.1093/ndt/17.7.1166, PubMed 12105236

Publications 2001

Asberg A, Midtvedt K, Vassbotn T, Hartmann A (2001)
Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients
Nephrol Dial Transplant, 16 (7), 1465-70
DOI 10.1093/ndt/16.7.1465, PubMed 11427642

Hjelmesaeth J, Hartmann A, Midtvedt K, Aakhus S, Stenstrøm J, Mørkrid L, Egeland T, Tordarson H, Fauchald P (2001)
Metabolic cardiovascular syndrome after renal transplantation
Nephrol Dial Transplant, 16 (5), 1047-52
DOI 10.1093/ndt/16.5.1047, PubMed 11328915

Hjelmesaeth J, Midtvedt K, Jenssen T, Hartmann A (2001)
Insulin resistance after renal transplantation: impact of immunosuppressive and antihypertensive therapy
Diabetes Care, 24 (12), 2121-6
DOI 10.2337/diacare.24.12.2121, PubMed 11723094

Midtvedt K, Hartmann A, Foss A, Fauchald P, Nordal KP, Rootwelt K, Holdaas H (2001)
Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril
Transplantation, 72 (11), 1787-92
DOI 10.1097/00007890-200112150-00013, PubMed 11740389

Midtvedt K, Hartmann A, Holdaas H, Fauchald P (2001)
Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double-blind randomised comparative trial
Clin Transplant, 15 (6), 426-31
DOI 10.1034/j.1399-0012.2001.150611.x, PubMed 11737121

Midtvedt K, Ihlen H, Hartmann A, Bryde P, Bjerkely BL, Foss A, Fauchald P, Holdaas H (2001)
Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study
Transplantation, 72 (1), 107-11
DOI 10.1097/00007890-200107150-00021, PubMed 11468543

Publications 2000

Midtvedt K, Neumayer HH (2000)
Management strategies for posttransplant hypertension
Transplantation, 70 (11 Suppl), SS64-9
PubMed 11152234

Publications 1999

Asberg A, Attramadal H, Midtvedt K, Sund S, Hartmann A, Berg KJ (1999)
Gene expression of the renal endothelin system in renal transplant recipients on cyclosporine A based immunosuppression
Transplantation, 67 (7), 1056-60
DOI 10.1097/00007890-199904150-00020, PubMed 10221493

Hjelmesaeth J, Midtvedt K, Aakhus S, Hartmann A (1999)
[Cardiovascular disease after kidney transplantation]
Tidsskr Nor Laegeforen, 119 (25), 3784-8
PubMed 10574058

Midtvedt K (1999)
[Infections in renal transplant recipients in Norway]
Tidsskr Nor Laegeforen, 119 (24), 3621-3
PubMed 10563182

Publications 1998

Lehne G, Nordal KP, Midtvedt K, Goggin T, Brosstad F (1998)
Increased potency and decreased elimination of lamifiban, a GPIIb-IIIa antagonist, in patients with severe renal dysfunction
Thromb Haemost, 79 (6), 1119-25
PubMed 9657435

Midtvedt K (1998)
A clinical study of some major early complications following renal transplantation
Medical Department B, National Hospital of Norway, Oslo, 1 b. (flere pag.)
BIBSYS 982095228, ISBN 82-7722-089-8

Midtvedt K (1998)
[Clostridium difficile-associated diarrhea treated with homologous feces]
Tidsskr Nor Laegeforen, 118 (11), 1758
PubMed 9621767

Midtvedt K, Hartmann A, Hjelmesaeth J, Lund K, Bjerkely BL (1998)
Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplant recipients
Nephrol Dial Transplant, 13 (2), 427-31
DOI 10.1093/oxfordjournals.ndt.a027841, PubMed 9509457

Midtvedt K, Hartmann A, Midtvedt T, Brekke IB (1998)
Routine perioperative antibiotic prophylaxis in renal transplantation
Nephrol Dial Transplant, 13 (7), 1637-41
DOI 10.1093/ndt/13.7.1637, PubMed 9681704

Midtvedt K, Hartmann A, Sund S (1998)
Can a diagnosis of renal allograft rejection be based on histology alone?
Clin Transplant, 12 (4), 300-2
PubMed 9686323

Publications 1997

Midtvedt K, Hartmann A, Brekke IB, Lyngdal PT, Bentdal O, Haugen G (1997)
Successful pregnancies in a combined pancreas and renal allograft recipient and in a renal graft recipient on tacrolimus treatment
Nephrol Dial Transplant, 12 (12), 2764-5
DOI 10.1093/ndt/12.12.2764, PubMed 9430893

Publications 1996

Midtvedt K, Hartmann A, Bentdal O, Brekke IB, Fauchald P (1996)
Bilateral nephrectomy simultaneously with renal allografting does not alleviate hypertension 3 months following living-donor transplantation
Nephrol Dial Transplant, 11 (10), 2045-9
DOI 10.1093/oxfordjournals.ndt.a027094, PubMed 8918720

Midtvedt K, Stokke ES, Hartmann A (1996)
Successful long-term treatment of post-transplant erythrocytosis with losartan
Nephrol Dial Transplant, 11 (12), 2495-7
DOI 10.1093/oxfordjournals.ndt.a027224, PubMed 9017632

Midtvedt K, Tafjord AB, Hartmann A, Eide TC, Holdaas H, Nordal KP, Draganov B, Sødal G, Leivestad T, Fauchald P (1996)
Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection
Transplantation, 62 (1), 38-42
DOI 10.1097/00007890-199607150-00008, PubMed 8693541

Publications 1994

Gullestad L, Midtvedt K, Dolva LO, Norseth J, Kjekshus J (1994)
The magnesium loading test: reference values in healthy subjects
Scand J Clin Lab Invest, 54 (1), 23-31
DOI 10.3109/00365519409086506, PubMed 8171268

Gullestad L, Nes M, Rønneberg R, Midtvedt K, Falch D, Kjekshus J (1994)
Magnesium status in healthy free-living elderly Norwegians
J Am Coll Nutr, 13 (1), 45-50
DOI 10.1080/07315724.1994.10718370, PubMed 8157853

Publications 1993

Midtvedt K (1993)
[Urinary tract infections]
Tidsskr Nor Laegeforen, 113 (5), 618-9
PubMed 7794286

Publications 1991

Midtvedt K (1991)
[Measurement of C-reactive protein gives valuable information on patients with various types of inflammation]
Tidsskr Nor Laegeforen, 111 (13), 1660-1
PubMed 2063373

Midtvedt K, Myrvang B (1991)
[Antibiotic prevention in permanent pacemaker implantation in Norway]
Tidsskr Nor Laegeforen, 111 (9), 1106-7
PubMed 2024255

Publications 1990

Madsen S, Midtvedt K (1990)
[Penicillin in clinical use--50 years]
Tidsskr Nor Laegeforen, 110 (30), 3884-7
PubMed 2281453

Publications 1985

Midtvedt K, Midtvedt T (1985)
Rapid determination of antibiotic susceptibility by a disc diffusion test for urgent clinical situations
Scand J Infect Dis, 17 (1), 131-2
DOI 10.3109/00365548509070435, PubMed 3992201

Publications 1982

Midtvedt T, Midtvedt K (1982)
Sport and infection
Scand J Soc Med Suppl, 29, 241-4
PubMed 6958046

MIDTVEDT T, MIDTVEDT K (1982)
SPORT AND INFECTION
Scand. J. Soc. Med. (29), 241-244

Publications 1980

Midtvedt T, Midtvedt K (1980)
[Athletics and infections]
Tidsskr Nor Laegeforen, 100 (12B), 859-62
PubMed 7404535